{"id":410311,"date":"2021-01-07T08:03:44","date_gmt":"2021-01-07T13:03:44","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=410311"},"modified":"2021-01-07T08:03:44","modified_gmt":"2021-01-07T13:03:44","slug":"cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/","title":{"rendered":"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference"},"content":{"rendered":"

<\/p>\n

CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference<\/b><\/p>\n

OXNARD, Calif.–(BUSINESS WIRE<\/a>)–CURE Pharmaceutical Holding Corp<\/a> (\u201cCURE\u201d or the \u201cCompany\u201d) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company\u2019s Chief Executive Officer Rob Davidson will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference<\/a> being held January 11-14. The presentation can be viewed beginning at 6:00 a.m. EST on January 11, 2021, and can be accessed here<\/a> through registration and will be available online until January 14.\n<\/p>\n

\nDuring the presentation, Davidson will discuss how CURE\u2019s recent acquisition of Sera Labs greatly expands the Company\u2019s positioning as a global health and wellness leader through added distribution channels and revenue streams. Furthermore, he will give additional insight into the importance of CURE\u2019s recently approved<\/a> Investigational New Drug (IND) application for its product CUREfilm Blue\u2122 intended to treat ertictile dysfunction (ED) which utilizes the Company\u2019s proprietary CUREfilm\u2122 drug delivery technology. Finally, he will discuss the Company\u2019s fiscal strategy for the upcoming year and new opportunities these milestones have created for the Company.\n<\/p>\n

\n“The last six months have been pivotal for CURE. To name just a few achievements, we repositioned our fiscal strategy and greatly expanded our operations with the acquisition of Sera Labs, welcomed Nicole Kidman as Sera Labs\u2019 strategic business partner and global brand ambassador and just received approval on our IND application for CUREfilm Blue\u2122,” Davidson said. \u201cAs we head into 2021, I look forward to sharing additional insight into these milestones with conference attendees and share how I believe CURE is well positioned to capitalize on our mission of delivering the promise of healthier lives to patients and consumers all over the world.\u201d\n<\/p>\n

About CURE Pharmaceutical Holding Corp.<\/b><\/p>\n

\nCURE Pharmaceutical\u00ae<\/sup> is the pioneering developer of CUREform\u2122, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.\n<\/p>\n

\nAs a vertically integrated company, CURE\u2019s 25,000 square foot, FDA-registered, NSF\u00ae<\/sup> and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.\n<\/p>\n

Forward Looking Statement<\/i><\/b><\/p>\n

Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (\u201cSecurities Act\u201d), and Section 21E of the Securities Exchange Act of 1934, as amended (\u201cExchange Act\u201d), which are usually identified by the use of words such as \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cexpects,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201cplans,\u201d \u201cprojects,\u201d \u201cseeks,\u201d \u201cshould,\u201d \u201cwill,\u201d and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect CURE\u2019s judgment as of the date of this press release. CURE disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.<\/i><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210107005306\/en\/<\/a><\/span><\/p>\n

Licensing Contact:
\n<\/span>
Jonathan Berlent
\n
Chief Business Officer
\n
Cure Pharmaceutical
\n
Jberlent@curepharma.com
\n<\/a>
516.660.9148\n<\/p>\n

Investment Contact:
\n<\/span>
Gary Zwetchkenbaum
\n
Plum Tree Consulting LLC
\n
gzplumtree@gmail.com
\n
<\/a>516.455.7662\n<\/p>\n

Media Contact:
\n<\/span>
Kathryn Brown
\n
CMW Media
\n
cure@cmwmedia.com
\n<\/a>
858.264.6600\n<\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Communications Health FDA General Health Pharmaceutical Public Relations\/Investor Relations<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp (\u201cCURE\u201d or the \u201cCompany\u201d) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company\u2019s Chief Executive Officer Rob Davidson will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference being held January 11-14. The presentation can be viewed beginning at 6:00 a.m. EST on January 11, 2021, and can be accessed here through registration and will be available online until January 14. During the presentation, Davidson will discuss how CURE\u2019s recent acquisition of Sera Labs greatly expands the Company\u2019s positioning as a global health and wellness leader … <\/p>\n

Continue reading “CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-410311","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp (\u201cCURE\u201d or the \u201cCompany\u201d) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company\u2019s Chief Executive Officer Rob Davidson will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference being held January 11-14. The presentation can be viewed beginning at 6:00 a.m. EST on January 11, 2021, and can be accessed here through registration and will be available online until January 14. During the presentation, Davidson will discuss how CURE\u2019s recent acquisition of Sera Labs greatly expands the Company\u2019s positioning as a global health and wellness leader … Continue reading "CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T13:03:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference\",\"datePublished\":\"2021-01-07T13:03:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/\"},\"wordCount\":760,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/\",\"name\":\"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-07T13:03:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference - Market Newsdesk","og_description":"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp (\u201cCURE\u201d or the \u201cCompany\u201d) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company\u2019s Chief Executive Officer Rob Davidson will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference being held January 11-14. The presentation can be viewed beginning at 6:00 a.m. EST on January 11, 2021, and can be accessed here through registration and will be available online until January 14. During the presentation, Davidson will discuss how CURE\u2019s recent acquisition of Sera Labs greatly expands the Company\u2019s positioning as a global health and wellness leader … Continue reading \"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-07T13:03:44+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference","datePublished":"2021-01-07T13:03:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/"},"wordCount":760,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/","name":"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-07T13:03:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005306r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cure-pharmaceutical-to-present-at-h-c-wainwright-bioconnect-2021-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=410311"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410311\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=410311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=410311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=410311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}